Fermenta Biotech (506414.BO) Stock Price

Fermenta Biotech Price

CLOSED
537.85
​
Market closed

Over the last 18 years Fermenta Biotech grew revenue by 17.0% annually, reaching 4.69 B INR. Earnings per share have grown at 5.8% per year over the last 18 years. For Fermenta Biotech, the net margin of 16.4% is up versus 12.1% a few years ago. At today's price the dividend yield works out to roughly 0.46%. The payout ratio is around 9% of earnings. The dividend has grown at 2.3% per year over the past 18 years.

Fermenta Biotech stock price

Access this data via the Eulerpool API

Fermenta Biotech business model & stock analysis

Fermenta Biotech Ltd. engages in the manufacturing and supply of Vitamin D3. The company is headquartered in Thane, Maharashtra and currently employs 550 full-time employees. The firm's segments include Chemicals/Bulk Drug and Property. The Chemicals/Bulk Drug segment is engaged in the manufacturing and selling of chemicals, primarily bulk drugs and enzymes. The Property segment is involved in renting and sale of properties. The firm has a diverse range of products and services that cater to various industries, such as pharmaceuticals, dietary and nutritional supplements, food and beverage fortification, animal feed, veterinary and rodenticides. The firm provides proprietary specialized technologies through its enzyme portfolio across the biopharmaceutical product life cycle. The company also offers a range of nutritional ingredients, such as fish oil-derived cholesterol for aquaculture nutrition, natural astaxanthin and vitamin AD2 premix, among others.

Frequently asked questions about Fermenta Biotech

5 analysts currently rate the Fermenta Biotech stock: 4 recommend buying, 1 holding and 0 selling.

Converted at the current exchange rate, the Fermenta Biotech share trades at 4.96 EUR (537.85 INR).

The revenue cannot currently be calculated for Fermenta Biotech.

The profit cannot currently be calculated for Fermenta Biotech.

The P/E ratio cannot be calculated for Fermenta Biotech at the moment.

The P/S cannot be calculated for Fermenta Biotech currently.

The Eulerpool Quality Score for Fermenta Biotech is 5/10.

The ISIN of Fermenta Biotech is INE225B01021. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Fermenta Biotech is 506414.BO. The ticker symbol is used to trade Fermenta Biotech shares on the stock exchange.

Fair ValueTerminal
521.71 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Pharmaceuticals
Number of shares
Employees
Revenue per Employee
8.54 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Jan 4, 1990
ISIN
INE225B01021
Cusip
Y2155C139
Market capitalization
15.53 B INRLarge Cap
52-Week Range
PEG
—
P/E ratio
P/Ee
—
P/S
P/Se
—
EV/EBIT
18.07
P/B Ratio
4.28
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
16.09 %
Dividend
Dividend yield
0.46 %
Payout Ratio
9.49 %
Dividend growth Ø5Y
3.71 %
Dividend payments per year
1
Dividend paid since
5 years
Dividend not reduced since
3 years
Dividend increased since
1 year
Dividend withholding tax
20.00 %
Last updated Oct 9, 2026, 4:56 PM

Fermenta Biotech Peer Group

Fermenta Biotech FIGI

FERMENTA:IN · BBG000CQQTH8FERMENTA:IB · BBG000CQQTT5